Key facts
- This page summarizes Bay Shore Trust's Form 4 filing for Telomir Pharmaceuticals, Inc. (TELO).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Nov 2024, 17:06.
Bay Shore Trust - 21 Nov 2024 Form 4 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- TELO
- Reported as of
- 21 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Nov 2024, 17:06:10 UTC
- Prior SEC filing
- 15 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian McNulty, Trustee
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Bay Shore Trust filed Form 4 for Telomir Pharmaceuticals, Inc. (TELO) on 25 Nov 2024.
Change
- Previous filing in this sequence was filed on 15 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TELO
transaction
Derivative
Common Stock (right to buy)
Gift
- Transaction value
- Shares
- -100,000
- Change %
- -4.1%
- Price
- Shares after
- 2,339,025
- Date
- 21 Nov 2024
- Ownership
- By Trust
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $3.73
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Footnote F2
Bona Fide Gift. No compensation was given to the donor for the gifting of securities.